Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Liniker

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|November 24, 2011
Temporary bilateral oculomotor nerve palsy as the sole presenting sign of a pituitary massElizabeth Liniker, Penny Hyatt
Cancer Cell|May 15, 2014
Endoplasmic reticulum stress in malignancyHanna J Clarke, Joseph E Chambers, Elizabeth Liniker, et al.
Pigment Cell & Melanoma Research|June 23, 2016
Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapyBenjamin Y Kong, Alexander M Menzies, Catherine A B Saunders, et al.
The Journal of Biological Chemistry|January 24, 2013
p53 and translation attenuation regulate distinct cell cycle checkpoints during endoplasmic reticulum (ER) stressSally E Thomas, Elke Malzer, Adriana Ordóñez, et al.
British Journal of Cancer|March 22, 2017
Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in MelanomaRicardo E Vilain, Alexander M Menzies, James S Wilmott, et al.
Cancer Research|July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistanceTakeshi Shimamura, Danan Li, Hongbin Ji, et al.
Nature|January 11, 2018
High response rate to PD-1 blockade in desmoplastic melanomasZeynep Eroglu, Jesse M Zaretsky, Siwen Hu-Lieskovan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|November 24, 2011
Temporary bilateral oculomotor nerve palsy as the sole presenting sign of a pituitary massElizabeth Liniker, Penny Hyatt
Cancer Cell|May 15, 2014
Endoplasmic reticulum stress in malignancyHanna J Clarke, Joseph E Chambers, Elizabeth Liniker, et al.
Pigment Cell & Melanoma Research|June 23, 2016
Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapyBenjamin Y Kong, Alexander M Menzies, Catherine A B Saunders, et al.
The Journal of Biological Chemistry|January 24, 2013
p53 and translation attenuation regulate distinct cell cycle checkpoints during endoplasmic reticulum (ER) stressSally E Thomas, Elke Malzer, Adriana Ordóñez, et al.
British Journal of Cancer|March 22, 2017
Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in MelanomaRicardo E Vilain, Alexander M Menzies, James S Wilmott, et al.
Cancer Research|July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistanceTakeshi Shimamura, Danan Li, Hongbin Ji, et al.
Nature|January 11, 2018
High response rate to PD-1 blockade in desmoplastic melanomasZeynep Eroglu, Jesse M Zaretsky, Siwen Hu-Lieskovan, et al.
Pageof 1